EcoDrugPlus

Growth Hormone-Releasing Hormone Receptor-Like

Ensembl ID : ENSCVAG00000003149
Gene Symbol: LOC107081956
2 Cross references
193 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCVAG00000011356
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCVAG00000006919
Gene Symbol: GUCY1A2
4 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCVAG00000011420
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSCVAG00000003500
Gene Symbol: HSP90AB1
3 Cross references
355 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSCVAG00000012549
Gene Symbol: LOC107092109
3 Cross references
512 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSCVAG00000013696
Gene Symbol: LOC107088138
2 Cross references
498 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSCVAG00000000934
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSCVAG00000008936
Gene Symbol: HRH2
1 Cross references
181 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSCVAG00000008848
Gene Symbol: HRH2A
1 Cross references
192 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSCVAG00000007383
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSCVAG00000002386
Gene Symbol: HDAC11
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).